Li Zhang, MD

Northwest Medical Specialties

Medical oncologist at Northwest Medical Specialties in the Pacific Northwest, specializing in genitourinary malignancies with a focus on prostate, bladder, and kidney cancers.

Published Articles (1)

Prostate Cancer in 2026: Personalizing ADT Duration, PARP Inhibitors Move Earlier, and a Bispecific That May Finally Crack Immunotherapy in This Disease

June 8, 2026

From ADT duration optimization to PARP inhibitors in hormone-sensitive disease and a promising T-cell engager in mCRPC, Dr. Li Zhang maps the shift toward precision in prostate cancer care in 2026.